期刊
EXPERT OPINION ON INVESTIGATIONAL DRUGS
卷 22, 期 6, 页码 751-763出版社
INFORMA HEALTHCARE
DOI: 10.1517/13543784.2013.802768
关键词
beta-cell failure; ER stress; inflammation; insulin resistance; type 2 diabetes; tyrosine kinase inhibitors
资金
- [FAPESP: 2012/10338-6]
- [CNPq-INCT: 573856/2008-7]
Introduction: Some inhibitors of tyrosine kinase, as imatinib, erlotinib and sunitinib have antihyperglycemic effects but the mechanisms are not totally clear. Areas covered: It is well established that insulin resistance and beta-cell failure are hallmarks of type 2 diabetes mellitus (DM2). The present review will discuss the molecular mechanisms that account for insulin resistance and beta-cell failure in DM2, and also the effect of tyrosine kinase inhibitors in these processes. Expert opinion: A better understanding of how these drugs improve the two most important mechanisms of DM2 associated with suggestions of clinical studies will lead to improve the treatment of this disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据